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ABSTRACT 
          Perfluorooctanoic acid (PFOA), a man-made stable perfluoroalkyl acid is used widely in 
the process of synthesizing fluoropolymers for the manufacturing of various daily products such 
as Teflon. PFOA is extremely persistent in the environment and can be detected in many 
organisms including humans. Different studies have shown the potential of PFOA causing 
diseases in animals. Previous study has suggested PFOA-induced hepatocellular damage over 
time with unusual fat deposit and liver enlargement. To closely study the underlying mechanisms 
of PFOA induced hepatocellular damage. Liver hepatocellular carcinoma cell line HepG2 was 
used as a model to study the PFOA induced inflammation in vitro on the cellular, epigenetic and 
metabolic levels. HepG2 cells were treated with 20 μM, 100 μM, 200 μM, 400 μM PFOA 
dissolved in DMSO for 48 hours before harvested for DNA, RNA and assays. The mRNA 
expression levels of cell cycle and proliferation genes are affected significantly, as well as the 
mRNA expression levels of TETs. Due to the unusual fat deposits in PFOA treated animals 
observed in prior studies, essential lipid metabolism gene were also studied and of which the 
mRNA expression levels are also changed, especially those regarding beta-oxidation pathway 
and lipid synthesis. Global methylation level of HepG2 cells was found to be in overall inverse 
proportion with different dosages of PFOA and had corresponding trends with mRNA expression 
of most genes of interest. Lipid quantification has also showed PFOA dose-dependent increase in 
the lipid accumulation in HepG2 cells. These evidences showed PFOA induced epigenetic 
changes play a major role in lipid metabolism genes activation and modulation in lipid 
metabolism, potentially causes abnormal fat deposit, liver inflammation and carcinogenesis. 
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CHAPTER 1  
INTRODUCTION 
          Perfluorooactanoic acid (PFOA) has been widely used as surfactant in industry in the 
process of synthesizing fluoropolymers to manufacture consumer product such as Gore-Tex and 
Teflon (Steenland et al., 2010). PFOA has a structure of eight-carbon chain therefore often also 
referred to as C8. As a member of perflluoroalkyl substances (PFASs), PFOA is a very stable 
compound due to its strong carbon-fluorine bonds (Prevedorous et al., 2006). PFOA has also 
been found to be one of the most found perfluorinated compounds (PFCs) in the environment 
(Goosey & Harrad, 2011) and a very persistent one (Buck et al., 2011). PFOA are especially 
harmful to aquatic lives, imply toxicity to ecosystems (Rodea-Palomares et al., 2015; Giesy et 
al., 2010). The half-life of PFOA in serum is up to 8.5 years of human individuals exposed to 
PFOA contaminated water (Seals et al., 2010). With the average intrinsic elimination half-life of 
2.4 years in humans (Russell, 2015), PFOA exhibits high bioaccumulation potential. PFOA has 
received a lot of concern since it has been detected in breast milk and cord serum (Apelberg et 
al., 2007; Llorca et al., 2010).  
          The accumulation of PFOA in animal bodies has led to multiple toxicities, such as 
genotoxicity, immunotoxicity, neurotoxicity and hepatotoxicity (DeWitt et al., 2008). Among 
those, hepatotoxicity was widely observed in different vertebrate animals, in the ways of unusual 
fat deposits, liver enlargement and hepatocarcinogenesis (Wu et al., 2018; Qazi et al., 2010; 
Benninghoff et al., 2011). Study also found positive association between PFOA exposure 
concentrations and serum alanine transaminase (ALT) level, which is a marker for hepatocellular 
damage (Gallo et al., 2012). Genotoxicity was also observed in human hepatoma cell line HepG2 
exposed to PFOA (Yao & Zhong, 2005). The prior literature on the effects of PFOA exposure 
has suggested that vertebrates primarily suffer inflammation in liver, pancreas (Kennedy et al., 
2004). Studies have also showed the potential causal relationship between PFOA and liver, 
pancreatic and other cancers (Biegel et al., 2001; Barry et al., 2013). 
          Due to its structural similarity to fatty acids, various studies have looked at correlation 
between PFOA exposure and different metabolism pathways, especially the peroxisome 
proliferator-activated receptors (PPARs). In a mouse study, even though study showed the 
requirement of PPARα in PFOA induced developmental toxicity, data showed large variability in 
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PPARs expression profile highly depending on the animal age (Abbott et al., 2012). Previous 
study also showed PFOA induced metabolic disruption in mouse neonates (Abbott et al., 2012). 
However, the underlying molecular mechanisms of PFOA-induced toxicity still remains unclear. 
          In non-human primates and rodents, PFOA has been found in relatively high concentration 
in liver tissue and have been related to liver enlargement. Study have shown association between 
hepatocellular adenoma and PFOA exposure in rats (Lau et al., 2007). Even though PFOA 
toxicity has been studies in many human studies, there is not thorough data on the toxicity of 
PFOA on human livers due to human study limitations (Lau et al., 2007). In order to better 
understand the mechanism associated with PFOA induced liver toxicity, our study explored the 
relationship between PFOA treatment and the expression of several rate-limiting lipid 
metabolism-related and β-oxidation pathway enzyme encoding genes and on the epigenetics 
level. Due to the benefits of controllable environment and relatively easy maintenance, we chose 
to explore the PFOA epigenetic toxicity on a human cell line in vitro. Originated from liver, 
hepatocellular carcinoma cell line HepG2 was chosen as our human liver in vitro model to carry 
out our experiments. 
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CHAPTER 2 
MATERIALS AND METHODS 
CHEMICALS AND TEST REAGENTS 
          The ammonium salt form of PFOA, Pentadecafluorooctanoic acid ammonium salt (CAS 
No. 3825-26-1) of ≥98.0% purity purchased from Sigma-Aldrich Corporation (St. Louis, MO, 
USA) was used in the experiments.  
           For the in vitro exposure of human hepatocellular carcinoma HepG2 cells, 
Pentadecafluorooctanoic acid ammonium salt was dissolved in dimethyl sulfoxide (DMSO; CAS 
No. D8418) from Sigma-Aldrich to obtain a stock solution of 0.1 M. Largest equivalent volume 
of DMSO was spiked into the control experiment group. Different volumes of stock solution 
were added into the cell culture media such that the final concentrations of PFOA in media were 
20 μM, 100 μM, 200 μM, 400μM, and the concentration of DMSO in all treatments and controls 
were lower than 0.4% v/v. It was empirically determined that 0.5% DMSO had negligible effect 
on cell response to MTT assay. 
 
CELL CULTURE 
          HepG2 cell line, Hep G2 [HEPG2] (ATCC® HB-8065™) was obtained from the 
American Type Culture Collection (ATCC; Manassas, VA, USA). HepG2 cells were cultured in 
the culture medium of 89% v/v Dulbecco's modified Eagle's medium with L-Glutamine and high 
glucose (ATCC 30-2002; Manassas, VA, USA), 10% v/v Fetal bovine serum (Gibco™ 
10082147; Thermo Fisher Scientific; Waltham, MA, USA), and 1% v/v Penicillin Streptomycin 
Solution, 100X (REF 30-002-Cl; CORNING; Corning, NY, USA) They are maintained in a 
humidified cell culture incubator at 37 °C as recommended.  
          Three groups of experiment were performed for each assay. All groups of experiment were 
performed at different time to achieve independence between groups. All experiments utilized 
cell cultures within a window of 6 passages. 
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MTT ASSAY 
          The [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazoliumbromide] (MTT) assay was 
used to determine the cell viability.  The MTT reagent purchased from Invitrogen (Cat. No. 
M6494) was prepared by dissolving 4 mg MTT per 1 mL sterile phosphate-buffered saline 
(Gibco™ 10010023; Thermo Fisher Scientific; ), then sterilized by filtering through a MILLEX 
GP 0.22 μm filter (Catalog No. SLGP033RS; MilliporeSigma; Burlington, MA, USA) and stored 
in darkness at 4 °C. MTT solvent was prepared by adding 0.33% v/v IGEPAL CA-630 in 
isopropanol, following by the pH adjusted to between 3 and 4 with 65 mM HCl aqueous 
solution.  
          For treatment experiment to investigate the effect of different concentrations of PFOA on 
HepG2 cell growth and proliferation, HepG2 cells were dissociated with trypsin (Gibco™ 
25300-062; Thermo Fisher Scientific; Waltham, MA, USA) and seeded into a 24-well plate at a 
density pf 20 000 cells per well. The number of cells provided high stability in results as optimal 
resolution in the linear range of MTT assay. Cells were cultured in appropriate DMEM based 
media for about 24 hours to achieve 30%-40% confluence before adding the corresponding 
concentration of PFOA dissolved in DMSO. Cultures were then allowed to grow for 48 hours. At 
this time the control cell culture was grown to 80%-90% confluence. Afterward the medium was 
substituted with phenol red free DMEM medium (Gibco™ 31053028; Thermo Fisher Scientific; 
Waltham, MA, USA) with 10% v/v Fetal bovine serum, and 1% v/v Penicillin Streptomycin 
Solution, 100X added.  
          MTT reagent was then added at 1: 10 to the existing medium, and incubated for another 4 
hours at 37 °C. The MTT solvent solution was added to stop the reaction at 1 to 1 ratio to the 
medium and incubated for 2 hours at room temperature. Absorbance was recorded at 570 nm 
wavelength with microplate reader (Synergy HT, BioTek; Winooski, VT, USA).  
          Cell viability is expressed as the percentage of absorbance values at different doses to their 
vehicle control. It was calculated with the formula [ODPFOA – ODblank] / [OD0.4%DMSO – ODblank] × 
100% 
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LIPID STAINING AND QUANTIFICATION 
          For the Oil Red O staining to determine the fat deposit of PFOA treated cells, the HepG2 
cell culture process is the same as MTT assay, except cells were cultured on poly-L-lysine coated 
cover glasses (GG-12-PLL, Neuvitro Corporation; Vancouver, WA, USA). After the 48 hours 
treatment, all cells were washed with PBS and fixed with 4% paraformaldehyde for 1 hour. Then 
the cells were stained with freshly prepared 0.5% Oil Red O solution in isopropanol for 2 hours. 
Afterward the cells were washed with molecular biology grade water (REF 46-000-CM, 
Corning; Manassas, VA, USA).  
          The slides were prepared and observed with Cytoviva darkfield microscope with 100X oil 
immersion lens and subsequently photographed with hyperspectral camera. The level of lipids 
was quantified with ImageJ Software and ENVI 4.8 software. 
 
GENE EXPRESSION ANALYSIS 
          For Gene expression analysis, we looked at the RNA expression profile on eight cell 
proliferation genes, six DNA methylation related genes, and seven lipid metabolism related 
genes. All genes and their encoding proteins are listed in Table 1. HepG2 cells were seeded 10 
000 per cm2 in T25 flasks and cultured till 20% - 30% confluence before adding the 20 μM, 100 
μM, 200 μM, 400μM of PFOA dissolved in DMSO into experimental groups and DMSO to 
vehicle control group. Cultures were then allowed into grow for 48 hours before cells were 
dissociated with tyrpsin for RNA extration.  
          The total RNA was isolated with TRIzol™ Reagent (Invitrogen™ 15596026; Thermo 
Fisher Scientific; Waltham, MA, USA). The quantity and quality of RNA extracted was tested 
with NanoDrop One (ND-ONE-W, Thermo Fisher Scientific; Waltham, MA, USA). Complete 
cDNA synthesis was achieved by performing reverse transcription with High Capacity cDNA 
Reverse Transcription Kit (Applied biosystems REF 4368814; Waltham, MA, USA) and 1 μg 
total RNA. Quantitative real-time polymerase chain reaction (qRT-PCR) mix was comprised of 
SYBR Green PCR Master Mix reagents (Applied biosystems REF 4367659; Waltham, MA, 
USA), synthesized cDNA and corresponding primers. All primers are designed using NCBI 
RefSeq Transcripts and BLAST and are listed in Table 2. qRT-PCR was performed on a Step 
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One Plus Real-Times PCR System (Applied biosystems, Waltham, MA, USA) with 20 μl per 
well of total reaction mixture in a 96-well plate. Reactions were run in duplicate with the 
following conditions. Started with initial denaturation at 95 °C for 3 min, followed by 35 cycles 
of denaturing at 95 °C for 15 s, annealing at 58 °C for 35 s, extension at 72 °C for 60 s. Finally, a 
melting curve stage consisting of 15 s at 95 °C, 60 s at 60 °C and a temperature ramp from 60 °C 
to 95 °C in increment of 0.3 °C for 15 s. The melting curve of each sample was examined to 
ensure the specify of each run with the StepOne software v2.3. After normalizing to the RNA 
expression of GAPDH. The relative RNA expression of each target gene in terms of ΔCT was 
calculated.  Quantification of the expressed transcripts was performed with 2–ΔΔCT method 
according to Schmittgen & Livak. 
 
GLOBAL METHYLATION ASSAY 
          Genomic DNA from HepG2 was extracted immediately after PFOA treatment period with 
PureLink Genomic DNA mini kit (Invitrogen K182002; Thermo Fisher Scientific; Waltham, 
MA, USA). The quantity and quality of DNA extracted was tested with NanoDrop One 
spectrophotometer (Thermo Fisher Scientific). The whole-genome methylation profile was tested 
with EpiGentek MethylFlash Global DNA Methylation (5-mC) ELISA Easy Kit (Colorimetric) 
according to the manufacturer's manual.  It was performed as a 96-well plate based colorimetric 
immunoassay. In each well, 100 ng of total DNA was attached to the well bottom surface, 
following by the DNA methylation marks labeling with monoclonal antibodies. Subsequently 
developed color was normalized with a set of standards with known methylation percentage. 
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CHAPTER 3 
RESULTS 
CELL VIABILITY 
          To determine the cytotoxicity at different dosage of PFOA on HepG2 cells, combined with 
prior knowledge on PFOA cytotoxicity of cell line (1), we started with concentrations of 10 μM, 
20 μM, 40 μM, 100 μM ,200 μM, and 400 μM, 600 μM. However, we found no significant 
difference between 10 μM, 20 μM, and 40 μM treatments in terms of both cell viability assay 
and gene expression of TETs and DNMTs. Therefore, we decided to only experiment with 20 
μM at lower concentrations. At 600 μM, most cells were dead due to the high dosage. So, it was 
also not included in the subsequent study. Initially we also studied results from HepG2 cells treat 
with different concentrations of PFOA for 24 hours, 48 hours and 72 hours. For 24 hours 
treatment give less significant separation in results corresponding different dosage probably due 
to insufficient time, and 72 hours treatment also gives less separation in results probably due to 
cell overgrowth and cell death, we did all subsequent studies with 48 hours incubation of PFOA. 
MTT assay was performed on PFOA treated HepG2 cells, representing the effect of different 
dosage of PFOA on HepG2 cell viability. There is no significant difference between negative 
control without any treatment and vehicle control with the same quantity of DMSO added as it 
was in the 400 μM PFOA treated media. 
          From 0 μM, 20 μM to 100 μM, cell viability increased in a dose-dependent fashion. While 
from 100 μM, 200 μM, to 400 μM, cell viability decreased in a dose-dependent fashion. 
According to MTT assay, cell viability was at highest after 100 μM PFOA treatment for 48 
hours, which was increased by about 40%. While cell viability was at lowest after 400 μM PFOA 
treatment for 48 hours, which was decreased by about 20% comparing with control (Figure 1). 
 
EFFECT ON CELL APOPTOSIS, PROLIFERATION AND CYCLE GENES 
          Due to the strong influence PFOA had on cell viability and reported influences PFASs 
have on cell metabolism and proliferation (Hagenaars et al., 2013; Peng et al., 2013; Yan et al., 
2015), we had a closer look at several genes related to apoptosis, cell proliferation and cell cycle 
via relative RNA expression profiles. We have seen a slight increase in lower concentration of 
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PFOA treatment and strong dose-dependent decrease in higher concentration PFOA treatment in 
BAX expression in HepG2 cells. Cell cycle genes CCNA2, CCNE1, CCNB1 were also tested with 
their gene expression profile. All those cyclin encoding genes showed similar trends in gene 
expression. At lower concentration of PFOA, there were small increases. As the dosage 
increases, the gene expression of those genes decreased significantly and mostly dose-
dependently. Further we examined the expression of four genes, CDKN1A, CDK4, RPS6, 
KITLG, related to cell proliferation. Cyclin-dependent kinase inhibitor 1 encoding CDKN1A 
increased significantly with higher concentration of PFOA treatment, including over 6-fold 
increase at 200 μM and over 8-fold increase at 400 μM. Cyclin-dependent kinase 4 encoding 
CDK4 expression profile has shown minor changes at different concentrations but mostly 
decreased at higher dosages. RPS6 expression was decreased at 20 μM PFOA and increased at 
all higher concentrations of PFOA. The expression of Kit Ligand encoding gene KITLG has also 
decreased with all concentrations of PFOA. All detailed relative mRNA expressions of cell 
apoptosis, cell cycle, and cell proliferation related genes are presented in Figure 2. 
 
EFFECT ON LIPID METABOLISM AND TRANSPORT GENES 
          The structural similarity between PFOA backbone and fatty acids suggests that they may 
interfere with the cellular lipid metabolism and transportation (Luebker et al., 2002; Ophuang & 
Singer, 1980; Wang et al., 2013; Ye et al., 2009). To better understand the effect of PFOA on 
lipid metabolism, we analyzed the expression of selected genes involved in liver cell lipid 
metabolism and transport. We also examined intracellular lipid accumulation via lipid staining 
and quantification. 
          From a pool of lipid metabolism related genes, we selected those that are largely expressed 
in liver tissue since HepG2 was our model of the study. Out of those genes, a few of them have 
substantial alternation in RNA expression corresponding to the change in PFOA treatment. 
Among the beta-oxidation involved acyl-CoA dehydrogenase enzyme encoding genes, ACAD11 
and ACADM have a small increase in expression with the PFOA dosage increment. Along with 
the increased expression of catabolism related genes, the expression of a lipid synthesis related 
gene ACSL1 has increased much more significantly in a dose-dependent manner. At 400 μM 
PFOA treatment level, the expression of ACSL1 was increased by about 6-fold. Furthermore, 
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FABP1 which encodes fatty acid binding protein and responsible for fatty acid uptake, transport 
and metabolism had decreased expression has decrease in expression along of PFOA increments. 
ACOX2 encodes acyl-CoA oxidase 2 involved in the fatty acids degradation in peroxisomes had 
decreased expression. The expression of HMGCR also decreased in a dose-dependent fashion. 
Overall, we observed increased expression of lipid metabolism genes in different aspects (Figure 
5). 
 
EFFECT ON INTRACULLULAR LIPID STORAGE 
          Next we had a closer look on the intracellular lipid storage in PFOA treated HepG2 cells. 
After treatment, cells grown on coverslips were immediately fixed with 10% neutral buffered 
formalin. Cells were subsequently stained using 0.3% Oil Red O in 60% isopropanol solution. 
Following we observed the cells with dark field microscope equipped with 100X oil immersion 
lens and imaged with hyperspectral camera. Hyperspectral data were analyzed to calculate the 
average intensity at 663nm wavelength. Higher intensity indicates higher density of lipid deposit. 
From Figure 6. we can see that lipid deposit decreased at 20 μM PFOA treatment and increased 
at 100 μM, 200 μM and 400 μM PFOA treatments. 
 
EPIGENETIC TOXICITY OF PFOA: EFFECT ON GENOME-WIDE METHYLATION AND ITS 
MECHANISM 
          Since we have seen strong dose-dependent changes in some selected genes. For better 
understanding the effect of PFOA on genome-wide gene expression status, we analyzed the 
global methylation for HepG2 after different concentration treatment of PFOA. The 
quantification of genome-wide 5-mC content in treated cells showed significant dose-dependent 
reduction of methylation at higher concentrations of PFOA from 100 μM to 400 μM. While there 
was a minor increase in global methylation level in 20 μM PFOA treated HepG2, compared to 
control (Figure 7). 
          To study the mechanism of how the methylation level changes and the possible 
involvement of Tet Methylcytosine Dioxygenases and DNA Methyltransferases, we evaluated 
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the mRNA relative expression profiles of corresponding genes TET1, TET2, TET3, and DNMT1, 
DNMT3A, DNMT3B in PFOA treated HepG2 cells. We have observed significant dose-
dependent changes in all three TETs, which was also proportional to global methylation level 
changes. TET1 expression had an overall trend of decreasing with the increasing dosage of 
PFOA. While TET2 and TET3 had overall trend of increasing with the increasing dosage of 
PFOA (Figure 3). But the behavior is opposite at 20 μM PFOA. However, there was not a 
definite trend in the expression of all three DNMTs (Figure 4). 
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CHAPTER 4 
DISCUSSION 
          From the MTT assay results in Figure 1. we can see that PFOA increases the cell viability 
or metabolism rates in a dose-dependent fashion from no PFOA to 100 μM PFOA treatment after 
two days. While from 100 μM to higher dosage of PFOA, the viability of HepG2 cells decreases. 
Since we did not observe much cell death at treatment lower than 200 μM and cells start to die 
more at 400 μM. This indicates lower dose exposure of PFOA increases the proliferation of 
HepG2 cells and higher dose exposure may cause apoptosis. 
          Due to the strong influence PFOA had on cell viability and reported influences PFASs 
have on cell metabolism (Hagenaars et al., 2013; Peng et al., 2013; Yan et al., 2015) and our 
observation in the MTT assay, we had a closer look at the expression of several genes related to 
apoptosis, cell metabolism and cell cycle. Apoptosis regulator BAX plays its role in 
mitochondrial apoptotic process (Edlich et al., 2011). We have seen a strong dose-dependent 
decrease in BAX expression in PFOA treated HepG2 cells. Counteract with what we have 
observed in MTT assay, which shows possible apoptosis activation at higher dosage of PFOA, 
BAX express less as the PFOA dosage increases. This could indicate other mechanism that is 
causing cell death at higher PFOA treatment. Cell cycle genes CCNA2, CCNE1, CCNB1 were 
tested with their gene expression profile. CCNA2 encodes a cyclin that controls both G1/S and 
G2/M transition phases (Pagano et al., 1992). CCNE1 encodes a cyclin that is essential for the 
G1/S cycle transition control (Ohtsubo et al., 1995). Lastly CCNB1 encodes an essential cyclin 
that controls G2/M cell cycle transition (Brown et al., 2007). All those cyclin encoding genes 
showed similar trends in gene expression. At 20 μM PFOA, there were small increases in gene 
expression in two of these cell cycle genes. As the dosage increases, the gene expression of those 
genes decreased significantly and mostly dose-dependently. These could signify the irregular 
modulation of cell cycles due to PFOA exposure. Cyclin-dependent kinase inhibitor 1 encoding 
CDKN1A increased significantly with higher concentration of PFOA treatment, including over 8-
fold increase at 400 μM and over 11-fold increase at 200 μM. Previous study has shown that 
CDKN1A may be involved in responding to DNA damage via p53/TP53 mediated inhibition of 
cellular proliferation (Ducoux et al., 2001). Cyclin-dependent kinase 4 encoding CDK4 
expression profile has shown minor changes at different concentrations. RPS6 encodes 40S 
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ribosomal protein S6, which may play important role in controlling cell growth and proliferation 
via controlling the translation of certain classes of mRNA (Ruvinsky & Meyuhas, 2006). The 
expression of RPS6 was increased at higher concentrations of PFOA. The expression of Kit 
Ligand encoding gene KITLG has also decreased significantly with any concentration of PFOA 
(Figure 2). Overall, we can see the possible association between cell proliferation activation and 
PFOA exposure. 
          From a pool of lipid metabolism related genes, we selected those that are largely expressed 
in liver tissue since HepG2 was our model of the study. Out of those genes, a few of them have 
substantial alternation in RNA expression corresponding to the change in PFOA treatment. 
ACAD11 encodes acyl-CoA dehydrogenase enzyme preferring lipids with carbon chain length 
range from 20 to 26 (He et al., 2011). The enzyme is involved in beta oxidation pathway and 
have some unknown properties (He et al., 2011). Generally, the expression of ACAD11 has 
increased with the treatment of PFOA. ACADM encodes the medium chain specific preferring 
acyl-CoA, which catalyzes the initial step of mitochondrial fatty acid beta-oxidation pathway 
(Malecki et al., 2014). Its expression has also increased. Besides the increased expression of two 
catabolism related genes, the expression of ACSL1, a fatty acid coenzyme A ligase isozyme 
encoding gene, has increased significantly in a dose-dependent manner. ASCL1 works in the 
activation of long chain fatty acids synthesis (Lobo et al., 2009). The vast increase in expression 
of ACSL1 at higher dosages of PFOA signifies the increase of lipid anabolism at higher PFOA 
exposure. Furthermore, FABP1 which encodes fatty acid binding protein and responsible for 
fatty acid uptake, transport and metabolism had decreased expression. Therefore, FABP1 
expression decrease provides possible evidence that ACOX2 involved in the fatty acids 
degradation in peroxisomes had decreased expression. To sum up, we observed increased 
expression of lipid metabolism genes in different aspects. But out of all the expression of lipid 
synthesis related gene was most elevated, indicating a possible increased storage of lipids. 
(Figure 5) This hypothesis was further supported by the lipid quantification in HepG2 cells after 
Oil Red O staining and darkfield microscope hyperspectral imaging. With hyperspectral data, we 
can not only decide the lipid quantity based on the overall area stained but more precisely 
estimate the lipid quantity at each lipid storage droplet by looking at the average intensity. 
Between the two lipid droplets with same ORO stained area, higher average intensity at 663 nm 
wavelength indicates higher density of lipid stored. From our ORO stained cell images, we can 
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clearly see the increase in intracellular lipid storage at after higher concentration PFOA 
treatment. 
          From the previously mentioned gene expression we can see that different genes have 
responded to PFOA treatment differently. But we saw especially strong expression increase in 
lipid metabolism genes and cell proliferation genes. Together with large alternation in TET1, 
TET2, TET3 expression levels, we suspected epigenetic changes as a major game player in 
changing the cell proliferation and increase the lipid storage induced by PFOA. But not all TETs 
expression act the same way. In the future, we would want to examine how PFOA affect 
different TETs differently and what each TET Methylcytosine Dioxygenase does to lipid 
metabolism pathway activation. Nonetheless, our global methylation assay also showed overall 
trend of decrease in methylation with the increase of PFOA, indicating abnormal gene expression 
activation due to PFOA exposure. 
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CHAPTER 5 
CONCLUSION 
          This study has showed alternation in cell viability, gene expression, global methylation 
status of HepG2 cells treated with different concentrations of PFOA. We have observed different 
impacts of PFOA on HepG2 cells at low and high dosages. Overall, cell proliferation increases at 
lower doses of PFOA and decreases at higher doses, which was backed up with the increase in 
expression of cell proliferation genes. PFOA also causes increase in both lipid synthesis and 
degradation. But the overall impact of such alteration resulted into increased lipid deposit. 
Global methylation decreases at higher dosages of PFOA in a dose-dependent manner, which 
could indicate strong epigenetic toxicity of PFOA. While DNMTs may not be the crucial reason 
why such changes happen, TETs may play an important role in the global methylation alteration 
and abnormal lipid deposit in HepG2 cells due to PFOA exposure. However, additional 
experiments are needed to further determine the epigenetic toxicity of PFOA and its impact on 
lipid metabolism and liver diseases. 
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TABLE AND FIGURES 
Table 1. Genes and their encoding proteins, and the primer sequences designed for quantitative 
real-time polymerase chain reaction 
Gene Protein encoded Primer sequence (5'-3') 
TET1 Methylcytosine dioxygenase TET1 
Forward: CAGAACCTAAACCACCCGTG 
Reverse: TGCTTCGTAGCGCCATTGTAA 
TET2 Methylcytosine dioxygenase TET2 
Forward: GATAGAACCAACCATGTTGAGGG 
Reverse: TGGAGCTTTGTAGCCAGAGGT 
TET3 Methylcytosine dioxygenase TET3 
Forward: TCCAGCAACTCCTAGAACTGAG 
Reverse: AGGCCGCTTGAATACTGACTG 
DNMT1 DNA (cytosine-5)-methyltransferase 1 
Forward: TACCTGACGACCCTGACCTC 
Reverse: CGTTGGCATCAAAGATGGACA 
DNMT3A DNA (cytosine-5)-methyltransferase 3A 
Forward: TATTGATGAGCGCACAAGAGAGC 
Reverse: GGGTGTTCCAGGGTAACATTGAG 
DNMT3B DNA (cytosine-5)-methyltransferase 3B 
Forward: GGCAAGTTCTTCGAGGTCTCTG 
Reverse: TGGTACATGGCTTTTGGATAGGA 
BAX Apoptosis regulator BAX 
Forward: CAAACTGGTGCTCAAGGCCC 
Reverse: GGGCGTCCCAAAGTAGGAGA 
CCNA2 Cyclin-A2 
Forward: AGTAAACAGCCTGCGTTCACC 
Reverse: GAGGGACCAATGGTTTTCTGG 
CCNE1 G1/S-specific cyclin-E1 
Forward: AAATGGCCAAAATCGACAGG 
Reverse: CGAGGCTTGCACGTTGAGTT 
CCNB1 G2/mitotic-specific cyclin-B1 
Forward: ATGACATGGTGCACTTTCCTCC 
Reverse: GCCAGGTGCTGCATAACTGG 
CDKN1A Cyclin-dependent kinase inhibitor 1 
Forward: TACCCTTGTGCCTCGCTCAG 
Reverse: GGCGGATTAGGGCTTCCTCT 
CDK4 Cyclin-dependent kinase 4 
Forward: CTGTGCCACATCCCGAACTG 
Reverse: GCCTCTTAGAAACTGGCGCA 
RPS6 40S ribosomal protein S6 
Forward: CGATGAACGCAAACTTCGTA 
Reverse: TTCGGACCACATAACCCTTC 
KITLG Kit ligand 
Forward: GGCAAATCTTCCAAAAGACTACATG 
Reverse: CTACCATCTCGCTTATCCAACAATG 
ACAD11 
acyl-CoA dehydrogenase family member 
11 
Forward: CAGGGTCGAATCTTCCGTGAT 
Reverse: GTCCTGATGAGCTGCAGCTT 
ACADM acyl-CoA dehydrogenase medium chain 
Forward: GAGCAGGCTCTGATGTAGCTG 
Reverse: TTCCTGGGGTATCTGCTTCC 
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Table 1. continued 
Gene Protein encoded Primer sequence (5'-3') 
ACSL1 
acyl-CoA synthetase long chain family 
member 1 
Forward: GACCTCTCCATGCAGTCAGT 
Reverse: GACACCTGTATTCCCCTCTGG 
FADS2 fatty acid desaturase 2 
Forward: CTGACCTGGAATTCGTGGGC 
Reverse: CATGTCCTCAGCCGTCTTCC 
FABP1 fatty acid binding protein 1 
Forward: TACAGTGGACAGTCTGGTCGG 
Reverse: GGCAGACCGATTGCCTTCATG 
ACOX2 acyl-CoA oxidase 2 
Forward: CTTTCTGGAGACGTGGCCTT 
Reverse: GGCCCTGAAGATATGTCCCATG 
HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase 
Forward: TGGGAATGCAGAGAAAGGTGC 
Reverse: AAGCTCCCATCACCAAGGAG 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
Forward: GAAGGTGAAGGTCGGAGTC 
Reverse: GAAGATGGTGATGGGATTTC 
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Figure 1. Evaluation of PFOA induced cytotoxicity in HepG2 cells. The cytotoxicity in HepG2 
cells was determined as the cell viability measured with MTT assay. Low concentration of 
PFOA caused increases in cell viability. While higher concentrations of PFOA caused dose-
dependent decreases in cell viability. Data are shown as mean ± sample standard deviation of 
nine independent replicates. 
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Figure 2. Effect on the expression of cell apoptosis, cycle and proliferation. Relative expression 
of cell apoptosis, cycle and proliferation genes. Data are shown as mean ± sample standard 
deviation of three independent replicates. 
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Figure 3. Effect on the expression of TETs. Relative expression of TET1, TET2, and TET3. Data 
are shown as mean ± sample standard deviation of three independent replicates. 
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Figure 4. Effect on the expression DNMTs. Relative expression of DNMT1, DNMT3A, 
DNMT3B. Data are shown as mean ± sample standard deviation of three independent replicates. 
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Figure 5. Effect on lipid metabolism and transport. Relative expression of cell lipid metabolism 
and transport genes. Data are shown as mean ± sample standard deviation of three independent 
replicates. 
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Figure 6. Quantification of intracellular lipid storage. (A-E) Oil Red O stained HepG2 imaged 
by dark field microscope hyperspectral camera. (F) Quantification of intracellular lipid in HepG2 
cells based on average intensity at 663 nm wavelength. 
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Figure 7. Global Methylation Assay. Global DNA methylation levels of HepG2 after different 
concentration PFOA treatments. Data are shown as mean ± sample standard deviation of three 
independent replicates. 
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